Loading organizations...
§ Private Profile · Boston, MA, USA
ZOE is a technology company.
ZOE develops a personalized nutrition program that leverages at-home testing and advanced scientific research to provide tailored dietary advice. The company utilizes proprietary research, including the world's largest in-depth nutrition studies, to analyze individual metabolic responses to food, blood sugar, blood fat, and gut microbiome health. Its core offering delivers personalized food scores and expert guidance through an application, enabling users to understand their unique biological reactions and optimize their eating habits.
The company was co-founded in 2017 by George Hadjigeorgiou, Tim Spector, and Jonathan Wolf. Their collective insight stemmed from a shared conviction that the prevailing "one-size-fits-all" approach to nutrition was insufficient, and that true health improvement required understanding an individual's unique biological responses to food. This led to the development of a science-backed platform designed to move beyond generic dietary recommendations.
ZOE’s customers are individuals looking for data-driven, personalized pathways to better health, seeking to move beyond conventional nutritional guidance. The company’s long-term vision centers on transforming the health of millions by continuously advancing nutritional science and making personalized dietary insights accessible. ZOE aims to empower individuals with the knowledge and tools to manage their metabolic health effectively.
ZOE has raised $89.5M across 6 funding rounds.
ZOE has raised $89.5M in total across 6 funding rounds.
ZOE has raised $89.5M in total across 6 funding rounds.
ZOE's investors include Coefficient Capital, Accomplice, Partech Ventures, Eli Manning, Errol Damelin, Pascal Gauthier, Tim Kendall, Flight Fund, Ahren Innovation Capital, Bennu, Coatue, Crosslink Capital.
ZOE has raised $89.5M across 6 funding rounds. Most recently, it raised $15.0M Series B in July 2024.
ZOE is a London-based health technology company specializing in personalized nutrition by leveraging scientific research, artificial intelligence (AI), and microbiome metagenomics to provide tailored dietary recommendations. It serves individuals seeking to improve their health and well-being through data-driven insights into their unique metabolism and gut microbiome. ZOE’s flagship product is a personalized nutrition program that combines at-home biological testing with AI-powered analysis to deliver actionable food scores and expert advice, helping users optimize their diet and overall health. The company has demonstrated strong growth momentum, with over 100,000 members benefiting from its program and its research published in leading journals such as *Nature Medicine*[1][2][3][4].
Founded in 2017, ZOE originated as a spin-out from King’s College London, driven by the belief that novel digital technologies could enable unprecedented depth and scale in human health research. The founders and leadership, including Wolf, former chief product officer at Criteo, brought expertise in scaling technology businesses. The idea emerged from large-scale nutritional studies, notably the PREDICT program, which is the world’s largest in-depth nutrition research initiative. Early pivotal moments include the pivot during the COVID-19 pandemic to launch the ZOE COVID Study app, which provided valuable data and insights during the crisis, demonstrating the company’s agility and scientific rigor[1][2].
ZOE rides the growing trend of personalized, data-driven health and nutrition, leveraging advances in AI, digital health, and microbiome science. The timing is favorable due to increasing consumer demand for individualized health solutions and the rise of preventive healthcare. Market forces such as rising chronic disease prevalence and the shift from one-size-fits-all dietary advice to precision nutrition support ZOE’s mission. By integrating large-scale biological data with AI, ZOE influences the broader ecosystem by setting new standards for personalized health interventions and demonstrating the commercial viability of science-driven nutrition tech[1][2].
ZOE is well-positioned to expand its impact as personalized nutrition gains mainstream acceptance. Future growth will likely be shaped by continued advances in AI, expanding biological datasets, and integration with broader digital health platforms. The company’s commitment to rigorous science and user-centric design suggests it will remain a leader in the personalized health space. Over the next decade, ZOE aims to catalyze a shift toward long-term, tech-enabled health improvement, potentially inspiring a new wave of companies that blend science and technology to enhance human well-being[1].